Avalo Therapeutics (AVTX) Asset Utilization Ratio (2016 - 2025)

Avalo Therapeutics (AVTX) has 10 years of Asset Utilization Ratio data on file, last reported at 0.0 in Q4 2025.

• Quarterly Asset Utilization Ratio rose 16.96% year-over-year to 0.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.0 (up 16.96% YoY) and the FY2025 annual result came in at 0.0, down 91.4% from the prior year.
• Asset Utilization Ratio rose to 0.0 in Q4 2025, from 0.0 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 0.56 in Q2 2023 to a low of 0.0 in Q3 2025.
• A 5-year average of 0.15 and a median of 0.08 in 2022 frame the typical range for Asset Utilization Ratio.
• Annual changes were most pronounced in 2022 — Asset Utilization Ratio jumped 739.91% — and 2024, when it slumped 98.76%.
• Tracing AVTX's Asset Utilization Ratio over 5 years: stood at 0.06 in 2021, then soared by 739.91% to 0.52 in 2022, then tumbled by 85.17% to 0.08 in 2023, then slumped by 95.38% to 0.0 in 2024, then grew by 16.96% to 0.0 in 2025.
• The last three Asset Utilization Ratio figures came in at 0.0 (Q4 2025), 0.0 (Q3 2025), and 0.0 (Q4 2024), per Business Quant data.